CA
CTIC

Commerzbank Aktiengesellschaft’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Commerzbank Aktiengesellschaft’s Portfolio CTIC Stock Details CTIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-35,690
Closed -$145K – 1040
2016
Q4 		$145K Sell
35,690
-2,306
-6% -$9.57K ﹤0.01% 934
2016
Q3 		$142K Sell
37,996
-4,603
-11% -$16.8K ﹤0.01% 874
2016
Q2 		$145 Buy
42,599
+453
+1% +$2.08K ﹤0.01% 951
2016
Q1 		$224K Sell
42,146
-23,240
-36% -$186K ﹤0.01% 944
2015
Q4 		$804K Sell
65,386
-15,750
-19% -$210K 0.01% 725
2015
Q3 		$1.19M Buy
81,136
+11,667
+17% +$202K 0.01% 544
2015
Q2 		$1.35M Buy
69,469
+4,856
+8% +$93.7K 0.01% 729
2015
Q1 		$1.17M Buy
+64,613
New +$1.45M 0.01% 753

Other funds holding CTIC

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Jane Street
Jane Street New York $93.1B AUM 61.18% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $16.2B AUM 16.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return